Release Date: 28/04/23 09:58 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 1.25MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%